Novelion's Aegerion faces sentencing in U.S. drug marketing case [Reuters]
NOVELION THERAPEUTICS INC COMMON SHARES (NVLN)
Last novelion therapeutics inc common shares earnings: 5/7 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novelion.com
Company Research
Source: Reuters
Novelion's Aegerion faces sentencing in U.S. drug marketing case | Reuters 3 Min Read BOSTON, Jan 30 (Reuters) - Aegerion Pharmaceuticals Inc is set to be sentenced on Tuesday for improperly marketing a cholesterol drug by a judge who rejected an initial plea deal and asked whether the drugmaker should be allowed to “collapse in disgrace.” U.S. District Judge William Young of Boston said in November that the original plea deal essentially restricted him to impose only the sentence agreed to by the U.S. Justice Department and Aegerion, a unit of Novelion Therapeutics Inc. Aegerion’s agreement was part of a deal to pay $40.1 million to resolve U.S. investigations of its drug Juxtapid. The company is now scheduled to plead guilty under a new deal that gives Young discretion on what penalties to impose. Young said the earlier plea deal reflected the “shocking disparity between the treatment of corporations and individuals in our criminal justice system.” He noted people typically go befor
Show less
Read more
Impact Snapshot
Event Time:
NVLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVLN alerts
High impacting NOVELION THERAPEUTICS INC COMMON SHARES news events
Weekly update
A roundup of the hottest topics